Muhammad Javad Muhammadi

Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial

F. Ismail-Beigi, M. Fathi, H. Khodabandehloo, 2021, BMC Cardiovascular Disorders.

Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial

F. Ismail-Beigi, M. Fathi, H. Khodabandehloo, 2020, BMC Cardiovascular Disorders.

The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial

F. Ismail-Beigi, M. Fathi, H. Chiti, 2022, Diabetology & Metabolic Syndrome.

Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study

C. Kaymaz, F. Kamangar, M. Moghimi, 2020, Thrombosis Research.

Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.

C. Kaymaz, F. Kamangar, M. Moghimi, 2020, Thrombosis research.